Results 191 to 200 of about 99,950 (263)

Targeting the ferritinophagy-lysosome axis as a therapeutic vulnerability in gastroenteropancreatic neuroendocrine tumors. [PDF]

Cell Rep Med
Cao Y, Cheng C, Yin Y, Yee SN, Zheng Y, Mahapatra S, Paturu R, Coleski A, VanAken S, Yang F, Pakkan R, Zhao Y, Bhattacharyya R, Miner SJ, Cao X, Mannan R, Li C, Sahai V, Ding K, Lyssiotis CA, Chinnaiyan AM, Qiao Y.   +21 more
europepmc   +1 more source

Advent of NK3R Antagonists for the Treatment of Menopausal Hot Flushes: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
Aaran H. Patel, Aureliane Pierret, Edouard G. Mills, Alexander N. Comninos, Waljit S. Dhillo, Ali Abbara   +5 more
wiley   +1 more source

Defining endoscopic candidacy for intermediate size rectal neuroendocrine tumors. [PDF]

World J Gastroenterol
Sheng YH, Chen QY, Li XM, Zhou ZX, Xue TL.   +4 more
europepmc   +1 more source

Kaempferol Protects Intestinal Health in Chinese Forest Musk Deer Possibly by Regulating Intestinal Microbiota and Inhibiting the NF‐κB/NLRP3 Signaling Pathway

Integrative Zoology, EarlyView.
Kaempferol modulates the tryptophan metabolism pathway by increasing the abundances of Christensenellaceae R7 group, Bacteroides, and Blautia and reducing that of Rikenellaceae RC9 gut group, thereby significantly increasing the levels of ILA and IAA. This process inhibits the activation of NF‐κB/NLRP3 signaling pathway, reduces pro‐inflammatory factor
Xiangyu Liu, Zhanjun Ren, Xiuzhu Sun, Shuhui Wang   +3 more
wiley   +1 more source

Cabozantinib and temozolomide in patients with advanced progressive neuroendocrine tumors: a phase 2 study. [PDF]

Nat Commun
Cives M, Della Vittoria Scarpati G, Clemente O, Lauricella E, Bracigliano A, Badalamenti G, Delrio P, Cannella L, Picone C, Ragno A, Chaoul N, Della Monica R, Di Mauro A, Pizzolorusso A, Sorino J, Buonaiuto M, Ingravallo G, Picozzi F, Pignataro P, Ferrara G, Porta C, Tafuto S.   +21 more
europepmc   +1 more source

Sentinel Lymph Node Biopsy in Clinically Node‐Negative Merkel Cell Carcinoma: An Update of the Westmead Hospital Experience

ANZ Journal of Surgery, EarlyView.
ABSTRACT Background Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous neuroendocrine malignancy with a high risk of nodal metastasis. Sentinel lymph node biopsy (SLNB) is used to stage clinically node‐negative disease and to guide adjuvant therapy decisions.
Julie Ahn, Julie R. Howle, Michael J. Veness   +2 more
wiley   +1 more source

Effect of metformin on pancreatic neuroendocrine tumors of multiple endocrine neoplasia type 1. [PDF]

J Neuroendocrinol
Kozlov SV, Agarwal SK, Guerin TM, Lawrence WC, Bassel LL, Graf A, Jha S, Weinstein LS, Blau JE, Del Rivero J.   +9 more
europepmc   +1 more source

Anastomotic Failure Is Not Affected by Anastomotic Technique in Minimally Invasive Two‐Stage Oesophagectomy

ANZ Journal of Surgery, EarlyView.
ABSTRACT Background The choice of anastomotic technique in minimally invasive oesophagectomy (MIO) may influence postoperative morbidity and long‐term outcomes. The primary aim of our study is to determine whether circular (CS) or linear‐stapled (LS) anastomosis is associated with anastomotic complications following MIO.
L. Vu, C. Cabalag, L. Ng, B. Choo, A. Hardley, S. Kariyawasam   +5 more
wiley   +1 more source

Expression of ATRX, DAXX, PDX1, ARX, and somatostatin receptors in pancreatic neuroendocrine tumors: a clinicopathological study. [PDF]

Front Endocrinol (Lausanne)
Ciobanu OA, Martin CS, Fica S, Herlea V, Tudose I, Vasilescu F, Sandra I, Barbu CG.   +7 more
europepmc   +1 more source

Gold‐standard evidence and best practice guidance for menstrual cycle‐informed clinical care: An overview for clinicians

British Journal of Clinical Psychology, EarlyView.
Abstract Objectives To synthesize current evidence and provide clinically actionable recommendations for integrating menstrual cycle‐related processes—particularly hormone sensitivity, Premenstrual Dysphoric Disorder (PMDD) and Premenstrual Exacerbation (PME)—into psychological assessment, formulation and treatment.
Ellen R. Lambert, Louise N. Nolan, Katja M. Schmalenberger   +2 more
wiley   +1 more source